Trend of Neovascular Glaucoma in Taiwan: A 15-year Nationwide Population-based Cohort Study

References

• Weiss DI, Shaffer RN, Nehrenberg TR. Neovascular gluacoma complicating carotid-cavernous fistula. Arch Ophthalmol. 1963;69:304–307. doi:10.1001/archopht.1963.00960040310007.
   PubMedGoogle Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224.
   PubMed Web of Science ®Google Scholar
• Wong TY, Chong EW, Wong WL, et al. Prevalence and causes of low vision and blindness in an urban malay population: the Singapore Malay Eye Study. Arch Ophthalmol. 2008;126(8):1091–1099. doi:10.1001/archopht.126.8.1091.
   PubMedGoogle Scholar
• Narayanaswamy A, Baskaran M, Zheng Y, et al. The prevalence and types of glaucoma in an urban Indian population: the Singapore Indian Eye Study. Invest Ophthalmol Vis Sci. 2013;54(7):4621–4627. doi:10.1167/iovs.13-11950.
   PubMed Web of Science ®Google Scholar
• Brown GC, Magargal LE, Schachat A, Shah H. Neovascular glaucoma. Etiologic considerations. Ophthalmology. 1984;91(4):315–320. doi:10.1016/S0161-6420(84)34293-2.
   PubMed Web of Science ®Google Scholar
• Liao N, Li C, Jiang H, Fang A, Zhou S, Wang Q. Neovascular glaucoma: a retrospective review from a tertiary center in China. BMC Ophthalmol. 2016;16:14. doi:10.1186/s12886-016-0190-8.
   PubMed Web of Science ®Google Scholar
• Shazly TA, Latina MA. Neovascular glaucoma: etiology, diagnosis and prognosis. Semin Ophthalmol. 2009;24(2):113–121. doi:10.1080/08820530902800801.
   PubMed Web of Science ®Google Scholar
• Al-Bahlal A, Khandekar R, Al Rubaie K, Alzahim T, Edward DP, Kozak I. Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia. Indian J Ophthalmol. 2017;65(10):969–973. doi:10.4103/ijo.IJO_33_17.
   PubMed Web of Science ®Google Scholar
• SooHoo JR, Seibold LK, Kahook MY. Recent advances in the management of neovascular glaucoma. Semin Ophthalmol. 2013;28(3):165–172. doi:10.3109/08820538.2012.730103.
   PubMed Web of Science ®Google Scholar
• Rodrigues GB, Abe RY, Zangalli C, et al. Neovascular glaucoma: a review. Int J Retina Vitreous. 2016;2:26. doi:10.1186/s40942-016-0051-x.
   PubMedGoogle Scholar
• Vasconcellos J, Costa VP, Kara-José N. Neovascular glaucoma: epidemiology and prognostic factors. Proposal of a flow chart to guide the treatment. Arq Bras Oftalmol. 1998;61:519–524.
   Google Scholar
• Sivak-Callcott JA, O’Day DM, Gass JD, Tsai JC. Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma. Ophthalmology. 2001;108(10):1767–1776;quiz1777, 1800. doi:10.1016/S0161-6420(01)00775-8.
   PubMed Web of Science ®Google Scholar
• Moraczewski AL, Lee RK, Palmberg PF, Rosenfeld PJ, Feuer WJ. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab. Br J Ophthalmol. 2009;93(5):589–593. doi:10.1136/bjo.2008.151472.
   PubMed Web of Science ®Google Scholar
• Olmos LC, Lee RK. Medical and surgical treatment of neovascular glaucoma. Int Ophthalmol Clin. 2011;51(3):27–36. doi:10.1097/IIO.0b013e31821e5960.
   PubMedGoogle Scholar
• Park SC, Su D, Tello C. Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab. Expert Opin Biol Ther. 2012;12(12):1641–1647. doi:10.1517/14712598.2012.721772.
   PubMed Web of Science ®Google Scholar
• Wakabayashi T, Oshima Y, Sakaguchi H, et al. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases. Ophthalmology. 2008;115(9):1571–1580, 1580.e1571–1573. doi:10.1016/j.ophtha.2008.02.026.
   Web of Science ®Google Scholar
• Iliev ME, Domig D, Wolf-Schnurrbursch U, Wolf S, Sarra GM. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma. Am J Ophthalmol. 2006;142(6):1054–1056. doi:10.1016/j.ajo.2006.06.066.
   PubMed Web of Science ®Google Scholar
• Hayreh SS, Rojas P, Podhajsky P, Montague P, Woolson RF. Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion. Ophthalmology. 1983;90(5):488–506. doi:10.1016/S0161-6420(83)34542-5.
   PubMed Web of Science ®Google Scholar
• Chen YT. An Examination of the Determination of Medical Capacity under a National Health Insurance Program. Int J Environ Res Public Health. 2019;16(7):1206. doi:10.3390/ijerph16071206.
   Web of Science ®Google Scholar
• Hsing AW, Ioannidis JP. Nationwide Population Science: lessons From the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175(9):1527–1529. doi:10.1001/jamainternmed.2015.3540.
   PubMed Web of Science ®Google Scholar
• Chen T-J, Chou L-F, Hwang S-J. Patterns of ambulatory care utilization in Taiwan. BMC Health Serv Res. 2006;6:54. doi:10.1186/1472-6963-6-54.
   PubMed Web of Science ®Google Scholar
• Hsieh CY, Su CC, Shao SC, et al. Taiwan’s National Health Insurance Research Database: past and future. Clin Epidemiol. 2019;11:349–358. doi:10.2147/CLEP.S196293.
   PubMed Web of Science ®Google Scholar
• Cheng CL, Lee CH, Chen PS, Li YH, Lin SJ, Yang YH. Validation of acute myocardial infarction cases in the national health insurance research database in taiwan. J Epidemiol. 2014;24(6):500–507. doi:10.2188/jea.JE20140076.
   PubMed Web of Science ®Google Scholar
• Ashaye AO, Adeoti CO. Neovascular glaucoma in a Nigerian African population. East Afr Med J. 2006;83(10):559–564. doi:10.4314/eamj.v83i10.9469.
   PubMedGoogle Scholar
• Lee DJ, Lam BL, Arora S, et al. Reported Eye Care Utilization and Health Insurance Status Among US Adults. JAMA Ophthalmol. 2009;127(3):303–310.
   Google Scholar
• Kramer HU, Ruter G, Schottker B, et al. Gender differences in healthcare utilization of patients with diabetes. Am J Manag Care. 2012;18(7):362–369.
   PubMed Web of Science ®Google Scholar
• Jiang YD, Chang CH, Tai TY, Chen JF, Chuang LM. Incidence and prevalence rates of diabetes mellitus in Taiwan: analysis of the 2000–2009 Nationwide Health Insurance database. J Formos Med Assoc. 2012;111(11):599–604. doi:10.1016/j.jfma.2012.09.014.
   PubMed Web of Science ®Google Scholar
• Chiang CE, Lin SY, Lin TH, et al. 2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases. J Chin Med Assoc. 2018;81(3):189–222. doi:10.1016/j.jcma.2018.01.001.
   PubMed Web of Science ®Google Scholar
• Wong KC, Wang Z. Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract. 2006;73(2):126–134. doi:10.1016/j.diabres.2006.01.007.
   PubMed Web of Science ®Google Scholar
• Chang CH, Shau WY, Jiang YD, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diabet Med. 2010;27(6):636–643. doi:10.1111/j.1464-5491.2010.03007.x.
   PubMed Web of Science ®Google Scholar
• Tseng FY, Lai MS, Syu CY, Lin CC. Professional accountability for diabetes care in Taiwan. Diabetes Res Clin Pract. 2006;71(2):192–201. doi:10.1016/j.diabres.2005.06.004.
   PubMed Web of Science ®Google Scholar
• Hsu CC, Tu ST, Sheu WH. 2019 Diabetes Atlas: achievements and challenges in diabetes care in Taiwan. J Formos Med Assoc. 2019;118(Suppl 2):S130–S134. doi:10.1016/j.jfma.2019.06.018.
   PubMedGoogle Scholar
• Lin JC, Shau WY, Lai MS. Sex- and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan. JAMA Ophthalmol. 2014;132(8):922–928. doi:10.1001/jamaophthalmol.2014.859.
   PubMed Web of Science ®Google Scholar
• Lazcano-Gomez G, Soohoo JR, Lynch A, et al. Neovascular Glaucoma: A Retrospective Review from a Tertiary Eye Care Center in Mexico. J Curr Glaucoma Pract. 2017;11(2):48–51. doi:10.5005/jp-journals-10028-1222.
   PubMedGoogle Scholar
• Al-Rasheedi AAS. The role of educational level in glycemic control among patients with type II diabetes mellitus. Int J Health Sci. 2014;8(2):177. doi:10.12816/0006084.
   Google Scholar
• Fernandez-Vigo J, Castro J, Macarro A. Diabetic iris neovascularization. Natural history and treatment. Acta Ophthalmol Scand. 1997;75(1):89–93. doi:10.1111/j.1600-0420.1997.tb00258.x.
   PubMedGoogle Scholar
• Hsu W-M, Liu J-H. Ophthalmology in Taiwan. Taiwan J Ophthalmol. 2014;4(2):59–62. doi:10.1016/j.tjo.2014.03.004.
   Google Scholar
• Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti‐vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Syst Rev. 2013;10:CD007920. doi:10.1002/14651858.CD007920.pub2.
   Google Scholar
• Sun Y, Liang Y, Zhou P, et al. Anti-VEGF treatment is the key strategy for neovascular glaucoma management in the short term. BMC Ophthalmol. 2016;16(1):150. doi:10.1186/s12886-016-0327-9.
   PubMed Web of Science ®Google Scholar
• SooHoo JR, Seibold LK, Kahook MY. The link between intravitreal antivascular endothelial growth factor injections and glaucoma. Curr Opin Ophthalmol. 2014;25(2):127–133. doi:10.1097/ICU.0000000000000036.
   PubMed Web of Science ®Google Scholar
• SooHoo JR, Seibold LK, Pantcheva MB, Kahook MY. Aflibercept for the treatment of neovascular glaucoma. Clin Exp Ophthalmol. 2015;43(9):803–807. doi:10.1111/ceo.12559.
   PubMed Web of Science ®Google Scholar
• Gheith ME, Siam GA, de Barros DS, Garg SJ, Moster MR. Role of intravitreal bevacizumab in neovascular glaucoma. J Ocul Pharmacol Ther. 2007;23(5):487–491. doi:10.1089/jop.2007.0036.
   PubMed Web of Science ®Google Scholar
• Zhou MW, Wang W, Huang WB, et al. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma. Chin Med J (Engl). 2013;126(8):1412–1417.
   PubMed Web of Science ®Google Scholar
• Ehlers JP, Spirn MJ, Lam A, Sivalingam A, Samuel MA, Tasman W. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma. Retina. 2008;28(5):696–702. doi:10.1097/IAE.0b013e3181679c0b.
   PubMed Web of Science ®Google Scholar
• Wu SC, Huang SC, Lin KK. Clinical experience with the Ahmed glaucoma valve implant in complicated glaucoma. Chang Gung Med J. 2003;26(12):904–910.
   PubMedGoogle Scholar